News from exscientia A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

22 Mar, 2019, 09:00 GMT Exscientia Continues Expansion with Establishment of a Subsidiary in Japan to Target the Pharmaceutical Market Across Asia

Exscientia, the world-leading Artificial Intelligence (AI)-driven drug discovery company announces the establishment of a subsidiary, Exscientia K.K...


13 Feb, 2019, 12:30 GMT Exscientia Hires Director of Data Engineering to Scale up its AI Drug Discovery Platform

Following a highly successful year and several drug discovery milestones using its flagship AI platform, Exscientia is pleased to welcome Andrew...


07 Jan, 2019, 13:05 GMT Exscientia Initiates Sixth AI Drug Discovery Partnership

Exscientia to receive up to CHF 67 million in upfront payments, research support, and milestone payments in discovery collaboration with Roche...


07 Jan, 2019, 13:00 GMT Exscientia Raises US$26 Million in Series B Financing Round to Accelerate Scaling as the Leading AI Drug Discovery Company

New Investors Celgene Corporation and GT Healthcare Capital Partners join Series A Investor Evotec Exscientia - the world-leading Artificial...


15 Nov, 2018, 09:00 GMT Exscientia Builds 'Full Stack' AI-driven Drug Discovery Capabilities Through Acquisition of Kinetic Discovery

Exscientia, the company leading the use of Artificial Intelligence (AI) in drug discovery, announces that is has acquired the biophysics specialists, ...


01 Nov, 2018, 08:00 GMT Leading AI-driven Drug Discovery Company Exscientia Expands to The Oxford Science Park

Facilities in The Schrödinger Building to bring together AI experts and biologists In a key point in its growth strategy, Exscientia, the innovative...


03 Oct, 2018, 09:00 BST Exscientia Appoints Georgy Egorov as Chief Financial Officer Bringing Significant Capital Markets and Strategic Development Expertise to Support Business Growth

Exscientia, the innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is pleased to announce the appointment of...


11 Dec, 2017, 09:00 GMT Exscientia Appoints Alex Snow, Founder of Oxford Innovation Sciences and Former CEO of Lansdowne Partners, as Deputy Chairman

Exscientia, the innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is pleased to announce the appointment of...


02 Jul, 2017, 01:00 BST Exscientia Enters Strategic Drug Discovery Collaboration with GSK

Exscientia, an innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is pleased to announce it has entered into...


15 Jun, 2017, 12:04 BST Exscientia Wins two Awards at Royal Society of Chemistry's 'Chemistry Means Business' Awards 2017

Exscientia, an innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is delighted to announce that its Chief...


09 May, 2017, 08:00 BST Exscientia Announces EUR250 Million Collaboration for a Multiple-Product Development and Licence Option Agreement with Sanofi

Initiates collaboration to develop bispecific-small-molecule drugs Exscientia, an innovative company at the forefront of Artificial Intelligence...


09 May, 2017, 08:00 BST Exscientia Announces EUR250 Million Collaboration for a Multiple-Product Development and Licence Option Agreement with Sanofi

Initiates collaboration to develop bispecific-small-molecule drugs Exscientia, an innovative company at the forefront of Artificial Intelligence...